Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment FCNCO Q1 2026 Earnings Preferred Shares Deliver Strong EPS Surprise Amid Steady Underlying Performance DNOW Q1 2026 Earnings Significant EPS Miss Highlights Profitability Challenges IMMP Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase NATH Q4 2024 Earnings EPS of 096 Signals Resilient Profitability RYZ Q1 2026 Earnings EPS Misses Estimates Stock Gains on Recovery Hopes